Investigational Site Number 124003

Edmonton T6G 2B7

0 studies enrolling now · 3 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Prostate Cancer Metastatic, Squamous Cell Lung Cancer

Studies at this site

• Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide — Stopped early
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed
• To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF) — Completed